<DOC>
	<DOCNO>NCT02137642</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability well effect RM-131 colonic motor sensory effect patient chronic constipation .</brief_summary>
	<brief_title>Study Evaluate Effects RM-131 Patients With Chronic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>1 . Able provide write informed consent prior study procedure , willing able comply study procedure . 2 . Subjects chronic IDIOPATHIC constipation , include experience constipation 12 week precede 12 month . Chronic constipation define Rome III criterion Functional Constipation 3 . Stable concomitant medication define change regimen least 2 week prior study period . 4 . Body mass index 1840 kg/m2 5 . Female patient must negative urine pregnancy test must lactate . For female able bear child , hormonal ( i.e. , oral , implantable , injectable ) singlebarrier method , doublebarrier method birth control must use throughout study . Female patient unable bear child must document medical history . ( i.e. , tubal ligation , hysterectomy , postmenopausal [ define minimum one year since last menstrual period ] ) . 1 . Unable unwilling provide inform consent comply study procedures 2 . Diagnosis secondary constipation e.g . underlie general neurological disease Parkinsonism , multiple sclerosis , disease associate peripheral neuropathy , iatrogenic constipation 3 . Structural metabolic disease affect GI system NOTE : Patients clinical suspicion upper low GI obstruction must evaluate per standard care obstruction rule screen 4 . Unable withdraw follow medication 48 hour prior colon study day throughout study : Medications alter GI transit include laxative , magnesium aluminum contain antacid , prokinetics , erythromycin , narcotic , aspirin , anticholinergic , tricyclic antidepressant , SNRI new antidepressant . With exception GoLYTELY take even prior colon study day . 4 Selective serotonin reuptake inhibitor ( SSRI ) antidepressants permissible low , stable dos . All medication shall review dis/approved principal investigator case case basis . Analgesic drug include opiate , NSAIDs COX2 inhibitor GABAnergic agent Benzodiazepines NOTE : stable dos thyroid replacement , estrogen replacement birth control ( adequate backup contraception druginteractions birth control conduct ) permissible . Drugs low therapeutic index , warfarin , digoxin , antiseizure medication 5 . History recent surgery ( within 60 day screen ) 6 . Acute chronic illness history illness , opinion Investigator , could pose threat harm patient obscure interpretation laboratory test result interpretation study data frequent angina , Class III IV congestive heart failure , moderate impairment renal hepatic function , poorly control diabetes , etc . 7 . Any clinically significant abnormality physical examination laboratory abnormality identify medical record , determine Investigator 8 . Acute GI illness within 48 hour initiation colonic study day 9 . Females pregnant breastfeed 10 . History alcohol substance abuse ; Alcohol use 2 day colonic study day 11 . Participation clinical study involve investigational medication within 30 day prior dose present study 12 . Any reason , opinion Investigator , would confound proper interpretation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>constipation</keyword>
</DOC>